Roche’s chronic cough program has sputtered to a halt. The drugmaker, which axed the program after the drug candidate ...

With an upfront payment of $50 million from Roche, the partnership will leverage Dyno Therapeutics’ in vivo gene therapy ...

Jefferies analyst Peter Welford noted that Roche’s pharma group came just slightly ahead of consensus expectations, driven by ...

Roche will use Dyno’s technology, through which Dyno applies AI and high-throughput in vivo data collection to engineering ...

About 500 children worldwide have received the gene therapy, including some families traveling abroad to gain access to it.

Founded in 1975, La Roche-Posay Laboratoire Dermatologique set out to create skin care solutions rooted in the healing ...

Over the last couple of years, one of the biggest stories in the stock market has been around pharmaceutical companies that ...

Swiss pharma giant Roche is refocusing its R&D investment on diseases like obesity that weigh heavily on healthcare budgets.

subject to coordination with Roche. P-BCMA-ALLO1 has received the FDA’s Orphan Drug designation for multiple myeloma and Regenerative Medicine Advanced Therapy (RMAT) designation for adult ...

And while we often feel the dryness on our face first, our hands and legs experience it, too, shares Dr. Azadeh Shirazi, ...

Roche (OTCQX:RHHBY) has received FDA approval ... It added that an FDA-approved biomarker test, such as Foundation Medicine’s FoundationOne Liquid CDx, can help identify patients with the ...